Observational studyBreast cancer (Tokyo, Japan)2026
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II-III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03).
Observational study in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough postmastectomy radiation therapy (PMRT) is a standard treatment for high-risk breast cancer, it adds the risk of complications after breast reconstruction (BR).
methodsThis multi-institutional cohort study included patients with stage II-III breast cancer-defined as tumor size ≥ 5 cm, lymph node involvement, and/or skin/chest wall invasion-who underwent immediate or delayed BR after mastectomy between January 2008 and December 2018. We retrospectively investigated the relationship between PMRT and BR-related complications after adjusting for patient characteristics and BR method.
resultsAmong 1138 patients (1101 immediate and 37 delayed BR), 427 (37.5%) underwent PMRT. The cohort included 238 (20.9%) patients with tumors ≥ 5 cm, 725 (63.7%) with 1-3 lymph node metastases, and 257 (22.6%) with ≥ 4. BR methods included 750 prosthetic, 385 autologous, and 3 fat graft procedures. The overall complication rates were 25.2% and 31.5% in the non-PMRT and PMRT groups, respectively (p = 0.028). In prosthetic BR, capsule contracture (p < 0.001) and infection (p = 0.014) were more frequent in the PMRT than the non-PMRT group, whereas no significant difference was observed in complication rates between two groups in autologous BR. Multivariate analysis identified PMRT as an independent risk factor for BR-related complications (odds ratio, 1.47; p = 0.032). The reoperation rate was similar in two groups.
conclusionsPMRT was associated with an increased incidence of BR-related complications in prosthetic BR, but not with reoperation, irrespective of the reconstruction method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.